126378-11-8

Basic information

• Product Name: 4-Pentynoic acid, phenylmethyl ester
• CAS NO: 126378-11-8
• Molecular Formula: C12H12O2
• Molecular Weight: 188.226
• Mol File: 126378-11-8.mol
• Article Data: 18

Chemical Properties

• CAS DataBase Reference: 4-Pentynoic acid, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Pentynoic acid, phenylmethyl ester(126378-11-8)
• EPA Substance Registry System: 4-Pentynoic acid, phenylmethyl ester(126378-11-8)

Safety Data

• Hazardous Substances Data: 126378-11-8(Hazardous Substances Data)

Upstream product

• 55183-44-3 4-pentynoic chloride 
• 100-51-6 benzyl alcohol 
• 6089-09-4 4-pentynoic acid 
• 100-39-0 benzyl bromide 

Downstream Products

• 179943-82-9 (4E,6Z)-6-Bromo-7-{(4S,5R)-5-[(3E,5E)-(1S,7R,8S,9R)-9-(tert-butyl-diphenyl-silanyloxy)-1,5,7-trimethyl-2-oxo-8-triethylsilanyloxy-deca-3,5-dienyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-hepta-4,6-dienoic acid benzyl ester 
• 528598-86-9 5-[3-(2,4-diamino-pyrimidin-5-ylmethyl)-4-methoxy-phenyl]-pent-4-ynoic acid benzyl ester 
• 1025971-40-7 5-[2-(2,4-diamino-5-methyl-pyrido[2,3-d]pyrimidin-6-ylmethyl)-4-methoxy-phenyl]-pent-4-ynoic acid benzyl ester 
• 860771-49-9 5-[3-(2,4-diamino-5-methyl-pyrido[2,3-d]pyrimidin-6-ylmethyl)-4-methoxy-phenyl]-pent-4-ynoic acid benzyl ester 
• 1028315-42-5 5-[5-(2,4-diamino-pteridin-6-ylmethyl)-5H-dibenzo[b,f]azepin-2-yl]-pent-4-ynoic acid benzyl ester 
• 1026147-88-5 C₄₄H₅₅BrN₄O₁₁ 
• 179943-83-0 (4E,6Z)-6-Bromo-7-{(4S,5R)-5-[(3E,5E)-(1S,7R,8S,9R)-9-(tert-butyl-diphenyl-silanyloxy)-8-hydroxy-1,5,7-trimethyl-2-oxo-deca-3,5-dienyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-hepta-4,6-dienoic acid 
• 179943-96-5 (4E,6Z)-6-Bromo-7-{(4S,5R)-5-[(3E,5E)-(1S,7R,8S,9R)-9-(tert-butyl-diphenyl-silanyloxy)-1,5,7-trimethyl-2-oxo-8-triethylsilanyloxy-deca-3,5-dienyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-hepta-4,6-dienoic acid 
• 126378-10-7 (E)-Benzyl 5-(tributylstannyl)pent-4-enoate 
• 137742-47-3 Benzyl 5-(4-phenylcyclohex-1-en-1-yl)-4-pentynoate 

Relevant articles and documents

The synthesis of corticosteroid-carborane esters for the treatment of rheumatoid arthritis via boron neutron capture synovectomy

Two corticosteroid-carborane esters were synthesized through the use of a BOP-Cl promoted esterification. The steroid-carborane conjugates are designed to selectively deliver boron to arthritic tissue for boron neutron capture synovectomy, a new therapeut

NOVEL LYSOPHOSPHATIDIC ACID DERIVATIVE

PROBLEM TO BE SOLVED: To provide a compound that specifically activates an LPA4 receptor, and a pharmaceutical composition containing the same. SOLUTION: This invention relates to a novel lysophosphatidic acid derivative that has an agonistic action on an LPA4 receptor and is useful for the prevention and/or treatment of a disease with angiodysplasia caused by the LPA4 receptor, or a disease associated with angiopathy, or symptoms associated therewith. This invention also relates to a pharmaceutical composition containing the lysophosphatidic acid derivative. SELECTED DRAWING: None COPYRIGHT: (C)2021,JPOandINPIT

GOLD (I)-PHOSPHINE 1,2,3-TRIAZOLE DERIVATIVES WITH ANTIOBIOTIC PROPERTIES

The present invention relates to gold (l)-phosphine 1,2,3-triazole compounds, and their use in a human or animal medicine. The present invention also relates to using such compounds for the prevention and/or treatment of an infection, i.e. inhibitors of growth of Gram-positive and/or Gram-negative bacteria. On another aspect the invention relates to the synthesis of the gold (l)-phosphine compounds of the invention and to their synthesis intermediates. The present invention finds applications in the medical, veterinary and/or chemical fields.